Search results
Results From The WOW.Com Content Network
gendigital.com. Footnotes / references Financials as of March 29, 2024 [update]. [ 1 ] Gen Digital Inc. (formerly Symantec Corporation and NortonLifeLock) is a multinational software company co-headquartered in Tempe, Arizona and Prague, Czech Republic. The company provides cybersecurity software and services.
DePuy Synthes (/ dəˈpjuː /) is a franchise of orthopaedic and neurosurgery companies. Acquired by Johnson & Johnson in 1998, its companies form part of the Johnson & Johnson Medical Devices group. DePuy develops and markets products under the Codman, DePuy Mitek, DePuy Orthopaedics and DePuy Spine brands.
Johnson & Johnson Plaza. Johnson and Johnson Plaza is the world headquarters for Johnson & Johnson in New Brunswick, New Jersey. The 16-story building opened in 1983. Its construction is considered to represent the beginning of revitalization of the city's central business district. [4][5]
Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split off its consumer healthcare business sector into a new publicly traded company, Kenvue.
Jennifer Taubert. Number of employees. 45.000. Parent. Johnson & Johnson. Website. janssen.com. Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a Belgian pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
Pages in category "Johnson & Johnson subsidiaries". The following 22 pages are in this category, out of 22 total. This list may not reflect recent changes.
This meant that Johnson & Johnson retained about 90.9% of the shares after the IPO. [18] [19] The IPO took place on May 4, 2023. [20] Shares of Kenvue were priced at $22, [21] [22] [23] implying an initial equity valuation for Kenvue of about $41 billion, and traded at $26.90 at the end of the first trading day. [24]
The Janssen COVID‑19 vaccine, (Ad26.COV2.S) sold under the brand name Jcovden, [1] is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, [24] and its Belgian parent company Janssen Pharmaceuticals, [25] a subsidiary of American company Johnson & Johnson. [26][27][28] It is a viral vector vaccine based on a ...